课题基金 / 基金详情

项目摘要

项目成果

ANDREW N HOOFNAGLE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Affinity reagents are essential to almost any modern scientific investigation of human disease. Antibodies are the most widely used family of affinity reagents and when cloned and produced in culture represent a powerful tool that can be continually regenerated. Many monoclonal antibodies boast strong interactions, slow off-rates, and good specificity. To supplement monoclonal antibodies, the Baker laboratory at the University of Washington has developed techniques to design small proteins de novo that bind molecules of interest. The overall goal of this Core entitled, “Affinity Regent Characterization Core,” is to provide the reagents needed for Projects 2 and 3 by (1) developing new monoclonal antibodies to be used in different assays, (2) labeling antibodies and novel small protein affinity reagents for use in CyTOF and brain imaging, and (3) carefully characterizing each reagent to ensure that different batches of affinity reagents behave similarly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
  • 批准号:
    10730284
  • 项目类别:
  • 资助金额:
    $86.77万
  • 财政年份:
    2023
  • 负责人:
    ANDREW N HOOFNAGLE
  • 依托单位:
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment
  • 批准号:
    10701480
  • 项目类别:
  • 资助金额:
    $79.25万
  • 财政年份:
    2023
  • 负责人:
    ANDREW N HOOFNAGLE
  • 依托单位:
Core - Biomarker Reference Laboratory
  • 批准号:
    10701483
  • 项目类别:
  • 资助金额:
    $4.0万
  • 财政年份:
    2023
  • 负责人:
    ANDREW N HOOFNAGLE
  • 依托单位:
Project 3: Development of multiplex assays for clinical monitoring of disease
  • 批准号:
    10573266
  • 项目类别:
  • 资助金额:
    $60.82万
  • 财政年份:
    2020
  • 负责人:
    ANDREW N HOOFNAGLE
  • 依托单位: